Contemporary Management of HIV 2020

Gain expert insights on the latest data supporting contemporary HIV treatment across settings, including patients who are newly diagnosed, virologically suppressed, or experiencing virologic failure with resistance and/or challenging comorbidities, along with new and emerging ART strategies.
Joseph J. Eron, Jr., MD
Program Director
Princy N. Kumar, MD, FIDSA, MACP
Program Director
Lisa Hightow-Weidman, MD, MPH
Princy N. Kumar, MD, FIDSA, MACP
David A. Wohl, MD

New Data From AIDS 2020

Download this expert-authored slideset to review new HIV study data on current ART regimens, investigational long-acting treatment, metabolic effects of ART, COVID-19 and HIV, and HIV prevention, presented at AIDS 2020: Virtual.

Joseph J. Eron, Jr., MD
Program Director
Princy N. Kumar, MD, FIDSA, MACP David A. Wohl, MD
Released: September 8, 2020

Experts review and discuss the clinical implications of new HIV study data on current ART regimens, investigational long-acting treatment, metabolic effects of ART, COVID-19 and HIV, and HIV prevention, presented at AIDS 2020: Virtual.

Joseph J. Eron, Jr., MD
Program Director
Princy N. Kumar, MD, FIDSA, MACP
Program Director
Lisa Hightow-Weidman, MD, MPH David A. Wohl, MD
Physicians: maximum of 1.25 AMA PRA Category 1 Credits Registered Nurses: 1.25 Nursing contact hours Pharmacists: 1.25 contact hours (0.125 CEUs) Released: September 11, 2020 Expired: September 10, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue